Novel Mutations in a Lethal Case of Lymphomatous Adult T Cell Lymphoma with Cryptic Myocardial Involvement.
Taraneh Hashemi ZonouzRami AbdulbakiBidhan C BandyopadhyayVictor E NavaPublished in: Current oncology (Toronto, Ont.) (2021)
The autopsy of a 65-year-old diabetic African American male revealed significant left myocardial involvement by adult T-cell leukemia/lymphoma (ATLL) despite normal pre-mortem fluorodeoxyglucose (FDG) uptake by positron emission tomography/computed tomography (PET/CT). Due to pre-existing diabetic cardiomyopathy with reduced ejection fraction (EF) and compatible imaging studies, cardiac lymphomatous involvement was not suspected. While peripheral blood was negative for leukemia, next-generation sequencing of a lymph node revealed at least eight novel mutations (AXIN1, R712Q, BARD1 R749K, CTNNB1 I315V, CUX1 P102T, DNMT3A S199R, FGFR2 S431L, LRP1B Y2560C and STAG2 I771M). These findings underscore a diagnostic pitfall in a rare lymphomatous variant of ATLL infiltrating myocardium and contribute to its molecular characterization.
Keyphrases
- positron emission tomography
- pet ct
- computed tomography
- african american
- lymph node
- left ventricular
- peripheral blood
- pet imaging
- type diabetes
- acute myeloid leukemia
- bone marrow
- high resolution
- single cell
- heart failure
- dna methylation
- magnetic resonance imaging
- pulmonary embolism
- neoadjuvant chemotherapy
- young adults
- copy number
- childhood cancer
- case control
- magnetic resonance
- dual energy
- fluorescence imaging
- mass spectrometry
- circulating tumor cells